Beta blockers, hemodialysis, QTC dispersion, chronic renal failure
Introduction: Jaundice is one of the commonest problems that can occur in a newborn. Many a times it is physiological in the newborn because liver is not mature enough to handle the bilirubin and there is an increased load of bilirubin due to a higher circulating erythrocyte volume, a shorter erythrocyte life span and a larger early labeled bilirubin peak. Objectives : 1) To know the effect of oxytocin for induction of labour in neonatal hyperbilirubenemia (NH). 2) Comparing Cord Serum Albumin level (CSA) with Cord Serum Bilirubin (CSB) in predicting neonatal hyperbilirubinemia. 3) To know the sensitivity, specificity, Positive predictive value and negative predictive value of CSA and CSB in predicting neonatal jaundice in term neonates. Method: Prospective study was performed on 789 healthy term neonates. Relevant maternal history is collected. Cord blood was collected from the healthy term neonates at birth, CSA and CSB measured. Neonate was assessed clinically every day. Total Serum Bilirubin (TSB) and blood group were assessed in neonate during 72-96 hours of life. TSB value ?17mg/dl is considered Neonatal Hyperbilirubinemia (NH) which requires intervention like phototherapy (PT) or Exchange transfusion (ET). Result: Out of 388 Infants born after oxytocin induced labour, 122 (56.48%) neonates developed NH (P=0.002).Neonatal hyperbilirubinemia was more significant in neonates with CSA levels ? 2.8g/dl and CSB levels ?2.1mg/dl. At cord serum albumin level ?2.8g/dl, sensitivity, specificity, PPV and NPV are 75.93 %, 68.06 %, 47.26 and 88.24 % respectively, for predicting NH at birth. At cord serum bilirubin level ?2.1g/dl, sensitivity, specificity, PPV and NPV are 96.30%, 70.86%, 55.47%and 98.07% respectively, for predicting NH at birth. Conclusion: Oxytocin should be used with caution in view of its ability to develop neonatal hyperbilirubinemia by inducing hemolysis. Both CSA and CSB are equally effective in predicting NH at birth. These study variables can be considered as neonatal screening tools for NH for term neonates.
– Friedman, L., Lewis, P. J., Clifton, P., and Bulpitt, C. J. (1978). Factors influencing the incidence of neonatal jaundice. British Medical Journal, 1, 1235-1237.
-Shally Awasthi and Hasibur Rehman. Early Prediction of Neonatal Hyperbilirubinemia. Indian J Pediatr 1998 ; 65 : 131-139.
-Rostami N, Mehrabi Y. Identifying the newborns at risk for developing significant hyperbilirubinemia by measuring cord bilirubin levels. J Arab Neonatal Forum 2005 ; 2 : 81-5.
– Davies DP, Gomersall R et al. neonatal jaundice and maternal oxytocin infusion. Br Med J. (1973) 3: 476-477.
– Ghosh A, Hudson FP. Oxytocic agents and neonatal hyperbilirubinaemia. Lancet. 1972 Oct 14;2(7781):823
-Oski, F(1975). oxytocin and neonatal hyperbilirubinemia. american journal of diseases of children, 129,1139-1140..
-Singhi S, Singh M. Oxytocin induction and neonatal hyperbilirubinaemia. Br Med J. 1977 Oct 15;2(6093):1028
-D’Souza, S W, et al,The effect of oxytocin in induced labour on neonatal jaundice; British Journal of Obstetrics and Gynaecology, 1979;86: 133-138.
-Guruprasad G. Bilirubin Metabolism- what we should know? J Neonatol. 2001;1:4-7.
– Piazza AJ, Stoll BJ. Jaundice and Hyperbilirubinemia in the Newborn. In Kliegman RM, Behrman RE, Jenson HB, Stanton BF eds. Nelson text book of Pediatrics: 18th ed. New Delhi; Saunders Elsevier,
-Chris HP van den akker, Henk Schierbeek et al. Human fetal albumin synthesis rates during different periods of gestation. Am J Clin Nutr 2008; 88:997-1003.
-Cloharty JP, Stork AR, Eichenwald EC, Hansen AR. Manual of neonatal care. 7th edn, Philadelphia: Lippincott Williams and Wilkins; 2012. Chapter 26, Neonatal Hyperbilirubinemia; p. 304 -339.
-Radmacher P, Massey C, Adamkin D. Hidden Morbidity With
-American Academy Of Pediatrics, Clinical Practice Guideline; Management of Hyperbilirubinemia in the Neonate Infant 35 or More Weeks of Gestation, Pediatrics 2004;114(1):297-316.
– Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. Canadian Medical Association Journal.2006; 175 (6): 561.
-Suchanda S et al. Cord blood albumin as a predictor of neonatal jaundice. International J. Biological and medical research 2011;2(1):436-438.
– Sun G, Wang YL, Liang JF, Du LZ. Predictive value of umbilical cord blood bilirubin level for subsequent neonatal jaundice. Zhonghua Er Ke Za Zhi 2007; 45 : 848-52.
-.Rudy Satrya, Sjarif Hidayat Effendi, Dida Akhmad Gurnida. Correlation between cord blood bilirubin level and incidence of hyperbilirubinemia in term newborns. Paediatrica Indonesiana 2009 ; 49(6) : 349-354.
-Trivedi et al. Cord Serum bilirubin and Albumin in Neonatal Hyperbilirubinemia. International Journal of Integrative sciences, Innovation and technology. Sec.A, 2013; 2(2):39-42.
How to Cite
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- An author must submit Copyright form After acceptance of the article.